Cardiol Therapeutics Inc. (CRDL)
1.23
-0.02 (-1.60%)
At close: Jan 15, 2025, 12:42 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Net Income | -28.13K | -30.93M | -31.64M | -20.64M | -13.68M | -15.89M | -1.66M |
| Depreciation & Amortization | 248.35 | 219.91K | 220.42K | 229.54K | 150.57K | 91.49K | 53.34K |
| Stock-Based Compensation | 4.17M | 5.01M | 8.50M | 2.77M | 3.27M | 1.65M | 237.27 |
| Other Working Capital | 679.62 | 5.89M | -2.27M | 7.22M | -1.76M | -7.17M | -128.33K |
| Other Non-Cash Items | -4.17M | 1.89M | 4.21M | 144.99K | 507.74K | 574.86K | 267.01K |
| Deferred Income Tax | n/a | -9.16M | -4.92M | n/a | n/a | 7.88M | n/a |
| Change in Working Capital | 746.80 | 5.75M | 76.52K | 8.32M | -1.62M | -5.20M | 48.38K |
| Operating Cash Flow | -25.18K | -27.22M | -23.55M | -9.19M | -11.38M | -10.89M | -1.29M |
| Capital Expenditures | -64.31 | -74.71K | -12.92K | -40.60K | -424.31K | -13.79K | -29.17K |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | -7.23K |
| Investing Cash Flow | -64.31 | -74.71K | -12.92K | -40.60K | -424.31K | -13.79K | -29.17K |
| Debt Repayment | -55.38K | -53.93K | -51.92K | -50.47K | -20.19K | 12.07M | 400.00K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 55.32K | -0.00 | 9.41M | -904.51K | 382.15K | -1.02M | -120.55K |
| Financial Cash Flow | -55.38 | -53.93K | 93.44M | 16.30M | 2.03M | 25.28M | 3.68M |
| Net Cash Flow | -24.54K | -24.43M | 69.87M | 7.07M | -9.78M | 14.37M | 2.36M |
| Free Cash Flow | -25.24K | -27.30M | -23.56M | -9.23M | -11.80M | -10.91M | -1.32M |